Ophthalmic System Including Accommodating Intraocular Lens and Remote Component

The European Patent Office published patent EP3876868A1 for Verily Life Sciences LLC covering an ophthalmic system with an accommodating intraocular lens and remote component. The patent was published on April 1, 2026, with A61F 2/16 classification. The patent grants intellectual property protection across 31 EPO designated member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Release Therapeutics SA Sustained-Release Implant Capsule

The European Patent Office granted patent EP4013381A1 to Release Therapeutics SA, Les Hôpitaux Universitaires de Genève, and Université de Genève for an implantable capsule designed for sustained-release drug delivery. The invention covers the capsule structure and composition with applications in medical treatment delivery.

Methods and Systems for Controlling a Prosthetic or Orthotic Device

The European Patent Office granted Össur Iceland EHF Patent EP4031074A1 covering methods and systems for controlling prosthetic or orthotic devices. The patent names inventors Einarsoon Arni and Langlois David with IPC classifications spanning A61F 2/50 through A61F 2/76. The patent is designated across 31 European states including DE, FR, GB, IT, ES, NL, SE, and CH.

Carl Zeiss Intraocular Lens Implant Patent EP4213767A1

Carl Zeiss intraocular lens implant, EP4213767A1, published 1st Apr

High Definition and Extended Depth of Field Intraocular Lens

The European Patent Office granted Patent EP4076281A1 to Z Optics, Inc. for a high definition and extended depth of field intraocular lens design. The patent covers optical engineering innovations in intraocular lens technology and is designated for all 31 European Patent Convention member states.

STEM FOR ARTIFICIAL JOINT AND METHOD FOR MANUFACTURING SAME

The European Patent Office published patent EP4129242A1 for a stem component for artificial joints, assigned to Saga University and Kyocera Medical Corporation. The patent covers the design and manufacturing method for artificial joint stems. Protection extends across EU member states plus additional European countries designated in the filing.

Cephea Valve Delivery System - Heart Valve Replacement

The European Patent Office published EP4138729A2 for Cephea Valve Technologies, Inc., covering a delivery system for heart valve replacement. The patent application was filed with claims related to A61F 2/24 (heart valve prostheses) and A61M 25/01 (catheter placement). The patent designates all EU member states plus Switzerland, Norway, and Turkey.

Extracellular vesicles biomarkers neuromuscular disorders patent published

Extracellular vesicles biomarkers neuromuscular disorders patent published

RIKEN Patent - Paraprevotella Bacterium Inhibits Trypsin Activity

The European Patent Office published patent EP3851517A1, granting RIKEN exclusive rights in 34 designated member states to a composition containing Paraprevotella bacterium for inhibiting trypsin activity. The composition contains the bacterium as the active ingredient and covers therapeutic and industrial applications of the trypsin inhibitor.

Combination therapy for treating muscular dystrophy patent

The European Patent Office granted Solidus Biosciences Patent EP3893940A1 covering combination therapies for treating muscular dystrophy, including genetic, protein-based, and viral vector approaches. The patent, classified under IPC codes A61K 48/00 and C12N 15/113, designates all EU member states plus Switzerland, Norway, and Turkey. This patent grant establishes intellectual property rights that may affect freedom-to-operate for competing therapeutic development programs.